hero-press overview share print facebook linkedin twitter

Dr. Arend Oetker hands over chairmanship for Hero Board

Published: Monday, December 10, 2012

Dr. Arend Oetker (73), the majority shareholder of the Hero Group, hands over the office of Chairman of the Board of Directors of the international Swiss food company to Dr. Hasso Kaempfe (62) on 1 January 2013. The new Board will consist of Dr. Hasso Kaempfe (Chairman), Herbert J. Scheidt (61, Vice-Chairman), Dr. Hagen Duenbostel (42) and Michael Pieper (66). Arend Oetker will continue to attend the Board meetings as Honorary Chairman.

Hasso Kaempfe is a German citizen and since 2012 a member of Hero's Board. The lawyer has been working for several mostly family-owned businesses as chairman or member of the Supervisory Board. He has many years of experience in leading internationally operating family companies, amongst others as Executive Board member of Tchibo and Chief Executive Officer of Mast-J├Ągermeister.

Arend Oetker, under whose leadership the Hero Group has developed in the recent years into a very successful internationally operating food company primarily in baby food and jams, will be Honorary Chairman of the Board. In this role, he will oversee the development of the Group in which he controls the majority.

Arend Oetker commented on the transfer of his responsibility as follows: "With Hasso Kaempfe we managed to gain an experienced individual for the office of Chairman who successfully lead medium-sized family companies. He understands our business and –together with our executive management– will continue the success story of Hero in our sense. I wish him every success and as the majority shareholder I look forward to working closely with him and the Board. With this step we have completed the planned reorganization of the Group and set the course for a successful development."

For further information:
Hero
Dr. Kiyan Nouchirvani
Senior Vice President Corporate Services
Tel: +41 62 885 52 04
Fax: +41 62 885 54 30
info@hero.ch
www.hero.ch